Medical Properties Trust, Inc. (MPT)
NYSE: MPT · Real-Time Price · USD
5.17
+0.04 (0.78%)
At close: Apr 28, 2026, 4:00 PM EDT
5.17
0.00 (0.00%)
After-hours: Apr 28, 2026, 5:56 PM EDT

Medical Properties Trust Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Medical Properties Trust stock has a target of 5.00, which predicts a decrease of -3.29% from the current stock price of 5.17.

Analyst Consensus: Hold
Target Low Average Median High
Price $5.00 $5.00 $5.00 $5.00
Change -3.29% -3.29% -3.29% -3.29%
* Price targets were last updated on Mar 2, 2026.

Analyst Ratings

According to 1 stock analyst, the rating for Medical Properties Trust is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Mar '26Apr '26
Strong Buy 00
Buy 00
Hold 11
Sell 00
Strong Sell 00
Total 11

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Hold
Maintains
$4.5$5
Hold Maintains $4.5$5 -3.29% Mar 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.02B
from 1.07B
Decreased by -4.76%
Revenue Next Year
1.07B
from 1.02B
Increased by 4.91%
EPS This Year
0.09
from -0.46
EPS Next Year
0.16
from 0.09
Increased by 71.20%
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
1.57B1.58B885.77M1.04B1.07B1.02B1.07B
Revenue Growth
23.90%0.67%-44.07%17.38%2.90%-4.76%4.91%
EPS
1.111.50-0.93-4.02-0.460.090.16
EPS Growth
37.04%35.14%----71.20%
Forward PE
-----55.6432.50
No. Analysts -----65
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027202820292030
High 1.2B 1.2B
Avg 1.0B 1.1B
Low 925.8M 917.5M

Revenue Growth

Revenue Growth 20262027202820292030
High
9.3%
21.5%
Avg
-4.8%
4.9%
Low
-13.5%
-10.0%

EPS Forecast

EPS 20262027
High 0.15 0.23
Avg 0.09 0.16
Low 0.05 0.12

EPS Growth

EPS Growth 20262027
High -
148.6%
Avg -
71.2%
Low -
26.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.